Evidence map›Paper›PMID 27656403›Full record

ArticleMolecular metabolism2016

The F-actin modifier villin regulates insulin granule dynamics and exocytosis downstream of islet cell autoantigen 512.

Hassan Mziaut, Bernard Mulligan, Peter Hoboth, Oliver Otto, Anna Ivanova, Maik Herbig, Desiree Schumann, Tobias Hildebrandt, Jaber Dehghany, Anke Sönmez and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The adaptor protein APPL2 controls glucose-stimulated insulin secretion via F-actin remodeling in pancreatic β-cells.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Hassan MziautPaul Langerhans Institute Dresden of the Helmholtz Center Munich at the Univ. Hospital, Faculty of Medicine Carl Gustav Carus, Technische Univ. Dresden, 01307 Dresden, Germany; German Center for Diabetes Research (DZD e.V.), 85674 Neuherberg, Germany.
Bernard MulliganPaul Langerhans Institute Dresden of the Helmholtz Center Munich at the Univ. Hospital, Faculty of Medicine Carl Gustav Carus, Technische Univ. Dresden, 01307 Dresden, Germany; German Center for Diabetes Research (DZD e.V.), 85674 Neuherberg, Germany.
Peter HobothPaul Langerhans Institute Dresden of the Helmholtz Center Munich at the Univ. Hospital, Faculty of Medicine Carl Gustav Carus, Technische Univ. Dresden, 01307 Dresden, Germany; German Center for Diabetes Research (DZD e.V.), 85674 Neuherberg, Germany.
Oliver OttoBiotechnology Center Dresden, 01307 Dresden, Germany.
Anna IvanovaPaul Langerhans Institute Dresden of the Helmholtz Center Munich at the Univ. Hospital, Faculty of Medicine Carl Gustav Carus, Technische Univ. Dresden, 01307 Dresden, Germany; German Center for Diabetes Research (DZD e.V.), 85674 Neuherberg, Germany.
Maik HerbigBiotechnology Center Dresden, 01307 Dresden, Germany.
Desiree SchumannBoehringer Ingelheim Pharma GmbH & Co. KG. Cardiometabolic Research, 88397 Biberach, Germany.
Tobias HildebrandtBoehringer Ingelheim Pharma GmbH & Co. KG. Cardiometabolic Research, 88397 Biberach, Germany.
Jaber DehghanyHelmholtz Centre for Infection Research (HZI), Braunschweig Integrated Centre for Systems Biology (BRICS), 38124 Braunschweig, Germany.
Anke SönmezPaul Langerhans Institute Dresden of the Helmholtz Center Munich at the Univ. Hospital, Faculty of Medicine Carl Gustav Carus, Technische Univ. Dresden, 01307 Dresden, Germany; German Center for Diabetes Research (DZD e.V.), 85674 Neuherberg, Germany.
Carla MünsterPaul Langerhans Institute Dresden of the Helmholtz Center Munich at the Univ. Hospital, Faculty of Medicine Carl Gustav Carus, Technische Univ. Dresden, 01307 Dresden, Germany; German Center for Diabetes Research (DZD e.V.), 85674 Neuherberg, Germany.
Michael Meyer-HermannHelmholtz Centre for Infection Research (HZI), Braunschweig Integrated Centre for Systems Biology (BRICS), 38124 Braunschweig, Germany.
Jochen GuckBiotechnology Center Dresden, 01307 Dresden, Germany.
Yannis KalaidzidisMax Planck Institute for Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Michele SolimenaPaul Langerhans Institute Dresden of the Helmholtz Center Munich at the Univ. Hospital, Faculty of Medicine Carl Gustav Carus, Technische Univ. Dresden, 01307 Dresden, Germany; German Center for Diabetes Research (DZD e.V.), 85674 Neuherberg, Germany; Max Planck Institute for Molecular Cell Biology and Genetics, 01307 Dresden, Germany. Electronic address: Michele.Solimena@tu-dresden.de.
Deutsches Diabetes-Zentrum e.V. · DECenter for Systems Biology Dresden · DEBoehringer Ingelheim (Germany) · DEHelmholtz Centre for Infection Research · DEMax Planck Institute of Molecular Cell Biology and Genetics · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveInsulin release from pancreatic islet β cells should be tightly controlled to avoid hypoglycemia and insulin resistance. The cortical actin cytoskeleton is a gate for regulated exocytosis of insulin secretory granules (SGs) by restricting their mobility and access to the plasma membrane. Prior studies suggest that SGs interact with F-actin through their transmembrane cargo islet cell autoantigen 512 (Ica512) (also known as islet antigen 2/Ptprn). Here we investigated how Ica512 modulates SG trafficking and exocytosis.

methodsTranscriptomic changes in Ica512 (-/-) mouse islets were analyzed. Imaging as well as biophysical and biochemical methods were used to validate if and how the Ica512-regulated gene villin modulates insulin secretion in mouse islets and insulinoma cells.

resultsThe F-actin modifier villin was consistently downregulated in Ica512 (-/-) mouse islets and in Ica512-depleted insulinoma cells. Villin was enriched at the cell cortex of β cells and dispersed villin (-/-) islet cells were less round and less deformable. Basal mobility of SGs in villin-depleted cells was enhanced. Moreover, in cells depleted either of villin or Ica512 F-actin cages restraining cortical SGs were enlarged, basal secretion was increased while glucose-stimulated insulin release was blunted. The latter changes were reverted by overexpressing villin in Ica512-depleted cells, but not vice versa.

conclusionOur findings show that villin controls the size of the F-actin cages restricting SGs and, thus, regulates their dynamics and availability for exocytosis. Evidence that villin acts downstream of Ica512 also indicates that SGs directly influence the remodeling properties of the cortical actin cytoskeleton for tight control of insulin secretion.

Indexed as

D, diffusion coefficientEGFP, enhanced green fluorescent proteinF-actinGranulesIca512Ica512, islet cell autoantigenInsulinIPGTT, intraperitoneal glucose tolerance testIVGTT, intravenous glucose tolerance testOGTT, oral glucose tolerance testRT-DC, real-time deformability cytometrySecretionSE, standard errorSG, secretory granulesTIRFM, total internal reflection fluorescence microscopyVillin

Identifiers

PMID27656403
PMCPMC5021679
OpenAlexW2415023292

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.